edoc

Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

Egli, A. and Bucher, C. and Dumoulin, A. and Stern, M. and Buser, A. and Bubendorf, L. and Gregor, M. and Servida, P. and Sommer, G. and Bremerich, J. and Gratwohl, A. and Khanna, N. and Widmer, A. F. and Battegay, M. and Tamm, M. and Hirsch, H. H. and Halter, J. P.. (2012) Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection, 40 (6). pp. 677-684.

[img]
Preview
PDF - Published Version
275Kb

Official URL: http://edoc.unibas.ch/dok/A6338078

Downloads: Statistics Overview

Abstract

BACKGROUND: The clinical characteristics of human metapneumovirus (hMPV)-associated lower respiratory tract infection (LRTI) after allogeneic hematopoietic stem cell transplantation (HSCT) is not well described. We describe the clinical course in eight HSCT recipients suffering from hMPV infection. METHODS: We prospectively included all patients with hMPV-associated LRTI after allogeneic HSCT during a period of 1 year. hMPV was diagnosed by multiplex polymerase chain reaction (PCR) from bronchoalveolar lavage (BAL). RESULTS: Eight patients with hMPV-associated LRTI were identified from 93 BAL samples. Three of the eight patients had co-infections with other pathogens. The median age of the patients was 45 years [interquartile range (IQR) 36.8-53.5], the median time posttransplant was 473 days (IQR 251-1,165), 5/8 patients had chronic graft-versus-host disease (cGvHD), and 6/8 patients received immunosuppression. Chest computed tomography (CT) scanning showed a ground-glass pattern in 7/8 patients. Seven of eight patients required hospitalization due to severe symptoms and hypoxemia. All were treated with intravenous immunoglobulin (IVIG), which was combined with oral ribavirin in six patients. The mortality rate was 12.5 % (1/8). CONCLUSIONS: hMPV-associated LRTI in allogeneic HSCT recipients are not uncommon and present with unspecific respiratory symptoms, ground-glass pattern in CT scanning, and co-infection.
Faculties and Departments:03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Applied Microbiology Research (Egli)
03 Faculty of Medicine > Departement Biomedizin > Former Units at DBM > Immunotherapy (Stern)
03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Infection Biology (Khanna)
03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Pulmonary Cell Research (Roth/Tamm)
03 Faculty of Medicine > Departement Biomedizin > Division of Medical Microbiology > Transplantation Virology (Hirsch)
UniBasel Contributors:Tamm, Michael and Stern, Martin Andreas and Hirsch, Hans H. and Egli, Adrian and Khanna, Nina and Battegay, Manuel E.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Urban & Vogel
ISSN:0300-8126
e-ISSN:1439-0973
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Related URLs:
Identification Number:
Last Modified:30 Nov 2017 10:19
Deposited On:10 Apr 2015 09:13

Repository Staff Only: item control page